N-Methyl-N-[(3R, 4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[3-d]pyrimidin-4-amine is used mainly as a key pharmaceutical intermediate and impurity reference standard in the synthesis and quality control of Tofacitinib, a Janus kinase (JAK) inhibitor for treating autoimmune diseases like rheumatoid arthritis, and serves as a building block in broader drug discovery and organic synthesis.
N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
| API Name | Tofacitinib citrate |
|---|---|
| CAS No | 477600-74-1 |
| Molecular Formula | C13H19N5 |
| Molecular Weight | 245.32 g/mol |
| Synonyms | N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
N-Methyl-N-[(3R, 4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[3-d]pyrimidin-4-amine is used mainly as a key pharmaceutical intermediate and impurity reference standard in the synthesis and quality control of Tofacitinib, a Janus kinase (JAK) inhibitor for treating autoimmune diseases like rheumatoid arthritis, and serves as a building block in broader drug discovery and organic synthesis.
The CAS number of N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine is 477600-74-1.
The molecular formula of N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine is C13H19N5.
The listed molecular weight of N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine is 245.32 g/mol.
N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine is listed as being used in connection with the following API: Tofacitinib citrate.
The listed synonym or IUPAC name for N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine is N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine.